Recent Analysts’ Ratings Changes for HCA Holdings (HCA)

HCA Holdings (NYSE: HCA) has recently received a number of price target changes and ratings updates:

  • 8/8/2017 – HCA Holdings was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “HCA Healthcare’s   shares have outperformed the industry year to date. Its top-line has been growing over the past several quarters on strong volumes and improved payor and service mix. A number of acquisitions made over the past many years have helped the company gain a strong foothold in the industry. During the second quarter results the company reported earnings of  $1.77 per share which lagged estimates by 1.7% but were up 5.4% year over year. The earnings miss can be traced back to an increase in expenses, which outpaced revenue growth. The company continues to suffer from weak commercial business that has faced declining volumes of admissions over the last four to five quarters. Its high bad debts  and disappointing international business are the other headwinds. The company has also trimmed its 2017 guidance.”
  • 8/5/2017 – HCA Holdings was downgraded by analysts at BidaskClub from a “sell” rating to a “strong sell” rating.
  • 7/27/2017 – HCA Holdings was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “HCA Healthcare’s earnings of $1.77 per share lagged estimates by 1.7% but were up 5.4% year over year. The earnings miss can be traced back to an increase in expenses, which outpaced revenue growth. The company continues to suffer from weak commercial business that has faced declining volumes of admissions over the last four to five quarters. Its high bad debts  and disappointing international business are the other headwinds. The company has also trimmed its 2017 guidance. Its shares have returned 10.3% year to date, underperforming the industry's gain of 14%. Nevertheless, its top-line has been growing over the past several quarters on strong volumes and improved payor and service mix. A number of acquisitions made over the past many years have helped the company gain a strong foothold in the industry.”
  • 7/26/2017 – HCA Holdings was downgraded by analysts at Bank of America Corporation from a “buy” rating to a “neutral” rating. They now have a $92.00 price target on the stock, down previously from $102.00.
  • 7/26/2017 – HCA Holdings had its “equal weight” rating reaffirmed by analysts at Morgan Stanley. They now have a $88.00 price target on the stock, down previously from $90.00.
  • 7/26/2017 – HCA Holdings had its price target lowered by analysts at Citigroup Inc. from $89.00 to $87.00. They now have a “neutral” rating on the stock.
  • 7/24/2017 – HCA Holdings was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 7/14/2017 – HCA Holdings was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “HCA Healthcare's shares have gained 10% in the past one year, outpacing the Zacks categorized Medical Hospital industry that declined by 0.2%. Its top line has been growing over the past several quarters due to robust volumes, improved payor and service mix, and effective cost management. Its numerous acquisitions over the past many years have helped it gain a strong foothold in the industry. Its solid balance sheet, characterized by consistent generation of cash flows that are used for investment activities, is another positive. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at $1.80 reflecting nearly 8.6% year over year growth. However, the company’s bad debts are likely to drain its bottom line. Also its commercial business remains under pressure. Regulatory uncertainty with respect to the repeal and replace of the Obamacare is other concern.”
  • 7/13/2017 – HCA Holdings was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $97.00 price target on the stock. According to Zacks, “HCA Healthcare's shares have gained 16.7% year to date, outpacing the Zacks categorized Medical Hospital industry that increased only 10%. Its top line has been growing over the past several quarters due to robust volumes, improved payor and service mix, and effective cost management. Its numerous acquisitions over the past many years have helped it gain a strong foothold in the industry. Its solid balance sheet, characterized by consistent generation of cash flows that are used for investment activities, is another positive. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at $1.80 reflecting nearly 8.6% year over year growth. However, the company’s bad debts are likely to drain its bottom line. Also its commercial business remains under pressure. Regulatory uncertainty with respect to the repeal and replace of the Obamacare is other concern.”
  • 6/28/2017 – HCA Holdings is now covered by analysts at Argus. They set a “buy” rating and a $100.00 price target on the stock.
  • 6/13/2017 – HCA Holdings was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating.

Shares of HCA Holdings, Inc. (NYSE HCA) opened at 77.81 on Friday. The company has a market capitalization of $28.11 billion, a P/E ratio of 10.43 and a beta of 0.67. HCA Holdings, Inc. has a 12-month low of $67.00 and a 12-month high of $91.03. The stock’s 50 day moving average is $83.76 and its 200-day moving average is $84.33.

HCA Holdings (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 25th. The company reported $1.75 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.80 by $0.05. The firm had revenue of $10.73 billion during the quarter, compared to analysts’ expectations of $10.76 billion. HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same period last year, the company earned $1.66 earnings per share. Analysts anticipate that HCA Holdings, Inc. will post $7.17 earnings per share for the current year.

In other news, insider Michael S. Cuffe sold 2,150 shares of the stock in a transaction on Monday, May 15th. The shares were sold at an average price of $84.52, for a total value of $181,718.00. Following the completion of the sale, the insider now directly owns 12,254 shares of the company’s stock, valued at $1,035,708.08. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Sandra L. Morgan sold 5,915 shares of the stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $82.74, for a total transaction of $489,407.10. Following the completion of the sale, the senior vice president now directly owns 2,420 shares of the company’s stock, valued at $200,230.80. The disclosure for this sale can be found here. Over the last three months, insiders sold 138,117 shares of company stock valued at $11,654,477. Corporate insiders own 2.90% of the company’s stock.

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Receive News & Ratings for HCA Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.